DUBLIN, Ireland, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it has been selected to Fortune’s “Best Small and Medium Workplaces” list. Horizon ranked #22 on the Best Medium Workplaces List.
“It is an honor to be recognized by Fortune as one of the 2016 Best Medium Workplaces,” said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc. “At Horizon, our mission is to improve the lives of patients with conditions such as rheumatoid arthritis, gout and very rare diseases. We are successful because of our diverse, creative and collaborative employees who are driven by a passion to improve the lives of those living with these challenging and often debilitating conditions.”
Horizon won this accolade based on employees' anonymous responses to an extensive survey about their levels of trust, pride and camaraderie at work. Great Place to Work® reviewed the survey results of more than 52,000 employees from hundreds of companies in the ranking process.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets nine medicines through its orphan, rheumatology and primary care business units. Horizon's global headquarters are in Dublin, Ireland and U.S. operations are in Lake Forest, Ill. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
About Great Place to Work®
Great Place to Work® is the global authority on high-trust, high-performance workplace cultures. Through proprietary assessment tools, advisory services, and certification programs, including Best Workplaces lists and workplace reviews, Great Place to Work® provides the benchmarks, framework, and expertise needed to create, sustain, and recognize outstanding workplace cultures. In the United States, Great Place to Work® produces the annual Fortune "100 Best Companies to Work For®" and a series of Great Place to Work® Best Workplaces lists, including lists for Millennials, Women, Diversity and over a half dozen different industries. Follow Great Place to Work® online at www.greatplacetowork.com and on Twitter at @GPTW_US.
About The Best Small and Medium Workplaces
Published together with our partner, Fortune, the Best Small & Medium Workplaces rankings are based upon feedback from more than 52,000 employees at Great Place to Work–Certified companies. Employees completed our anonymous Trust Index© survey, answering questions about how frequently they experience the behaviors that create a great workplace, including, for example, their assessment of the honesty and quality of communication by managers, degree of support for employees' personal and professional lives and the authenticity of relationships with colleagues.
Results from the survey are highly reliable, having a 95% confidence level and a margin of error of 5% or less. Winning a spot on this list indicates the company has distinguished itself from peers by creating a great place to work for all – not only do the majority of their employees experience the company as a great place to work, but this experience is consistent across the organization, regardless of gender, race/ethnicity, job role, or other personal characteristics. The companies with the highest employee ratings compared with organizations of the same complexity in size and scope were selected for the list. Companies with fewer than 100 employees compete for placement on the 50 Best Small Workplaces list, and companies between 100 and 999 employees compete for placement on the 100 Best Medium Workplaces list.
Contacts: Geoff Curtis Senior Vice President, Corporate Communications firstname.lastname@example.org
Source: Horizon Pharma plc